NYSE$FTRE
Fortrea Holdings Inc · Q3 2022 earnings
Q3 2022 earnings · · Investor relations
Briefing
8-K preview — no full financials in cached doc
Form 8-K discloses Q4 2023 book-to-bill ratio exceeded 1.2x and J.P. Morgan Healthcare Conference business preview via Exhibit 99.1, but the exhibit press release is not in the cached filing text. No revenue, net income, or EPS reported in the available document.
- Book-to-bill exceeded 1.2x in Q4 2023 per Item 2.02
- Exhibit 99.1 press release not included in cached text
- No income statement data extractable
Headline financials
Revenue & EPS history
Fortrea · Revenue · Quarterly
$168M
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 15 quarterly earnings reports · overlaid with Q3 2022
+1.3%
Avg return
Earnings day
-0.8%
Avg return
5 days after
+0.5%
Avg return
30 days after
53%
8 / 15 earnings
Positive
+26.0%
Q3 2024
Best reaction
-25.1%
Q4 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +18.5% | +25.9% | +40.5% | |
| Q4 2025 | +4.9% | +1.4% | -12.3% | |
| Q3 2025 | +23.4% | +15.3% | +46.8% | |
| Q1 2025 | -15.6% | -27.8% | -11.7% | |
| Q4 2024 | -25.1% | -22.9% | -45.8% | |
| Q3 2024 | +26.0% | +17.9% | +20.1% | |
| Q2 2024 | -11.7% | -11.4% | -18.4% | |
| Q1 2023 | -1.9% | -3.9% | -9.9% | |
| Q1 2024 | -12.7% | -16.6% | -24.8% | |
| Q4 2021 | +3.0% | +4.9% | +2.7% | |
| Q4 2023 | +3.2% | +6.7% | +6.0% | |
| Q3 2022 | +15.1% | -6.6% | -4.0% | |
| Q3 2023 | +15.1% | +13.0% | +14.1% | |
| Q2 2022 | -11.3% | +6.7% | +9.5% | |
| Q2 2023 | -11.3% | -14.9% | -5.9% | |
| Q1 2022 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro